SlidesetHIVViral Hepatitis and Liver DiseaseManaging Highly Treatment-Experienced Patients - Prof. Anca Streinu Cercel -View Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseThe Acute HCV Epidemic in MSM: What Have We Learned Thus Far? Christoph BoeseckeView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseART in Women: Which Drugs are Safe and What are the Challenges? - Dr. Annette HaberlView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseRSVSTI Diagnostics in the CEE Region - Pawel JakubowskiView Slideset
SlidesetHIVViral Hepatitis and Liver Disease2020: Have We Reached the 90-90-90 Targets? - Teymur NooriView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCOVID-19HIV and COVID-19 co-infection: An update Cristiana OpreaView Slideset
SlidesetHIVViral Hepatitis and Liver DiseasePrEP Implementation in the CEE Region: What are the Successes, What are the Barriers? Prof. Milosz ParczewskiView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseDebate: Do Integrase Inhibitors and/or TAF Lead to Weight Gain? Con Standpoint - Jürgen RockstrohView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseLong-Acting Therapies: Which Patients Will Benefit Most? - Dr. Sharon WalmsleyView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseGilleece, Yvonne - The Management of Hepatitis in PregnancyView Slideset